Natera hits Japan regulatory approval milestone; Omeros reaches 5-year peak
Natera shares rose after Japan regulatory approval for its cancer test; Omeros shares gained after a Cantor Fitzgerald upgrade and optimism around its lead drug’s commercialization.
Shares of Natera (NTRA) and Omeros (OMER) advanced on Tuesday after Natera secured regulatory approval in Japan for its cancer test and Cantor Fitzgerald upgraded Omeros amid rising optimism about the commercial potential of its lead drug. At the time of writing, OMER shares were…